GeraClinic / NHS cancer waiting times / NHS Gloucestershire ICB / Consultant Upgrade
NHS Gloucestershire ICB: Consultant Upgrade — 62-Day Cancer Waits
In April 2026, 85.4% of consultant upgrade cancer patients in NHS Gloucestershire ICB started treatment within 62 days — 96 patients on this pathway. NHS target: 85%. Official NHS England data.
What is the Consultant Upgrade cancer waiting time in NHS Gloucestershire ICB?
As of April 2026, 85.4% of consultant upgrade cancer patients in NHS Gloucestershire ICB started treatment within 62 days of referral (82 of 96 patients, NHS target: 85%), per NHS England Cancer Waiting Times data published June 2026. Gera re-dates this monthly.
| Measure | Value | Context |
|---|---|---|
| Patients on pathway | 96 | April 2026 |
| Within 62 days | 82 | Started treatment in time |
| Breaches | 14 | Did not meet 62-day standard |
| 62-day standard met | 85.4% | NHS target: 85% |
| Status vs target | MET | Target is 85% |
Other cancer pathways in NHS Gloucestershire ICB
NHS Gloucestershire ICB Consultant Upgrade cancer waits: FAQs
- What is the 62-day cancer waiting time for Consultant Upgrade in NHS Gloucestershire ICB?
- In April 2026, 85.4% of consultant upgrade cancer patients in NHS Gloucestershire ICB started treatment within 62 days of referral — covering 96 patients (82 within standard, 14 breaches). NHS target: 85%. Data: NHS England Cancer Waiting Times, June 2026.
- What does the Consultant Upgrade pathway mean?
- The Consultant Upgrade pathway covers patients who are upgraded onto the 62-day pathway by a clinician — typically because a patient attending for one condition is found to have suspected cancer. The 62-day clock starts from the upgrade decision date.
- How does NHS Gloucestershire ICB's Consultant Upgrade performance compare to England?
- The England average for the 62-day Consultant Upgrade pathway was not separately published at England level in the April 2026 extract. NHS Gloucestershire ICB's 85.4% performance can be compared against the overall England 62-day combined standard met rate and the NHS 85% target.
- What counts as a breach of the 62-day cancer standard?
- A breach occurs when a patient does not start their first definitive cancer treatment within 62 days of the relevant referral date (2-week wait, upgrade, screening referral, or breast symptomatic). In NHS Gloucestershire ICB for the Consultant Upgrade pathway in April 2026, there were 14 breaches out of 96 patients.
Faster consultant upgrade cancer assessment
NHS Gloucestershire ICB met the NHS 85% 62-day standard for the Consultant Upgrade pathway in April 2026. For even faster specialist access, GeraClinic connects you to UK-registered oncologists.
Contains public sector information published by NHS England and licensed under the Open Government Licence v3.0. Data: Cancer Waiting Times CRS Database, April 2026. Methodology.